Extensive Pelvic Plexiform Neurofibroma Presenting As Clitoromegaly in a 3-Year-Old Female: Presentation and Management with MEK Inhibitor

Abstract

Plexiform neurofibroma (PN) involvement of the external genitalia in patients with neurofibromatosis type I (NF1) is a rare cause of nonhormonal clitoromegaly. We present a 3-year-old female with known NF1 who presented with clitoromegaly. She was identified with an extensive pelvic mass involving the bladder wall, perineum, labia, clitoris, rectum, and sacral foramina. A partial cystectomy was performed, and histopathology was consistent with PN. She has been initiated on a mitogen activated protein kinase enzyme kinase inhibitor, trametinib, which has been effective in achieving partial radiographic response of the bladder mass over 5 months. Additionally, she has experienced clinical response to trematinib with resolution of urinary urgency and frequency since initiating treatment.

Keywords

plexiform neurofibroma - clitoromegaly - MEK inhibitor

Publikationsverlauf

Eingereicht: 23. Mai 2020

Angenommen: 13. Juli 2020

Artikel online veröffentlicht:
31. August 2020

• References

• 1 Iezzi ML, Lasorella S, Varriale G, Zagaroli L, Ambrosi M, Verrotti A. Clitoromegaly in childhood and adolescence: behind one clinical sign, a clinical sea. Sex Dev 2018; 12 (04) 163-174
• 2 Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers 2017; 3: 17004
• 3 Yesodharan D, Sudarsanan B, Jojo A. et al. Plexiform neurofibroma of clitoris. J Pediatr Genet 2017; 6 (04) 244-246
• 4 Pascual-Castroviejo I, Lopez-Pereira P, Savasta S, Lopez-Gutierrez JC, Lago CM, Cisternino M. Neurofibromatosis type 1 with external genitalia involvement presentation of 4 patients. J Pediatr Surg 2008; 43 (11) 1998-2003
• 5 Upadhyaya M. NF1 gene structure and NF1 genotype/phenotype correlations. Monogr Hum Genet 2008; 16: 26-62
• 6 Thomas WJ, Bevan HE, Hooper DG, Downey EJ. Malignant schwannoma of the clitoris in a 1-year-old child. Cancer 1989; 63 (11) 2216-2219
• 7 Papalia H, Audic F, Rivière GR, Verschuur A, André N. Quick and sustained clinical response to MEK inhibitor I in a NF1 patient with neurofibromas. Ecancermedicalscience 2018; 12: 862
• 8 McCowage GB, Mueller S, Pratilas CA. et al. Trametinib in pediatric patients with neurofibromatosis type 1-associated plexiform neurofibroma: a phase I/IIa study. J Clin Oncol 2018; 36 (Suppl. 15) 10504
• 9 Gross AM, Wolters PL, Dombi E. et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 2020; 382 (15) 1430-1442